Extending these findings, the HIF-1α-mediated release of TGF-β in hypoxic breast tumor microenvironment triggers Mesenchymal Stem Cells (MSCs) activation, thereby promoting growth, motility and invasive effects in breast cancer cells [149]. The gene discussed is HIF1A; the disease is breast neoplasm.